Cassava Sciences (SAVA) announced the retirement of James Kupiec, chief medical officer, effective May 9. The company also appointed Jack Moore as senior VP, clinical development, reporting to Rick Barry, CEO.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SAVA:
- Biotech Alert: Searches spiking for these stocks today
- Cassava Sciences announces Phase 3 REFOCUS-ALZ did not meet primary endpoint
- Cassava Sciences to resume trading at 8:35 am ET
- Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
- Cassava Sciences down 12% after simufilam doesn’t hit Alzheimer’s trial endpoint